These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8571340)

  • 21. [Pulmonary embolism disclosing activated protein C resistance].
    Strecker A; Bernardi F; Wolschies E; Hendricx S; Jude B
    Rev Mal Respir; 1996 Oct; 13(5):521-2. PubMed ID: 8999481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of APC resistance (activated protein C) for clinical practice].
    Lämmle B; Demarmels Biasiutti F; Wuillemin WA; Stucki B; Furlan M
    Praxis (Bern 1994); 1997 Jan; 86(5):154-61. PubMed ID: 9064734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischemic stroke.
    Albucher JF; Guiraud-Chaumeil B; Chollet F; Cadroy Y; Sié P
    Stroke; 1996 Apr; 27(4):766-7. PubMed ID: 8614946
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to activated protein C (APC): influence of factor V levels.
    Colucci M; Ciavarella N; Giliberti MG; Semeraro N
    Thromb Haemost; 1994 Dec; 72(6):987-8. PubMed ID: 7740475
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular mechanism for APC resistance in the absence of Arg 506 mutation: factor V gene sequencing strategy.
    Labrouche S; Javorschi S; Bernard P; Freyburger G
    Thromb Res; 1997 Jul; 87(2):263-7. PubMed ID: 9259118
    [No Abstract]   [Full Text] [Related]  

  • 27. [APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].
    Hakala L; Vahtera E; Krusius T; Rasi V
    Duodecim; 1995; 111(22):2143-51. PubMed ID: 9841174
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
    Zöller B; Holm J; Svensson P; Dahlbäck B
    Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
    Lowe GD; Rumley A; Woodward M; Reid E; Rumley J
    Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid detection of factor V: Q506 mutation using whole blood protein C resistance.
    Sacchi E; Duca F; Tagliabue L
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):799-800. PubMed ID: 9034562
    [No Abstract]   [Full Text] [Related]  

  • 34. Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels?
    Lunghi B; Scanavini D; Girelli D; Legnani C; Bernardi F
    J Thromb Haemost; 2005 Feb; 3(2):415-6. PubMed ID: 15670066
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor V Leiden-dependent APC resistance: improved sensitivity and specificity of the APC resistance test by plasma dilution in factor V-depleted plasma.
    Gouault-Heilmann M; Leroy-Matheron C
    Thromb Res; 1996 May; 82(3):281-3. PubMed ID: 8732632
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene.
    Chan LC; Bourke C; Lam CK; Liu HW; Brookes S; Jenkins V; Pasi J
    Thromb Haemost; 1996 Mar; 75(3):522-3. PubMed ID: 8701422
    [No Abstract]   [Full Text] [Related]  

  • 37. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.